Cochrane T, Enrico A, Gomez-Almaguer D, Hadjiev E, et al. Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial. Leuk Lymphoma 2021 Oct 11:1-11. doi: 10.1080/10428194.2021.1986217.
PMID: 34632935